Back to search
FDAFDA · Food and drugs·Recall number D-0398-2026

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

Published March 25, 2026 · Recall initiated: February 4, 2026

Summary

FDA records drug Class II recall D-0398-2026, published March 25, 2026 and initiated February 4, 2026. Recalling firm: SOMERSET THERAPEUTICS LLC; Status: Ongoing; Reported quantity: 62190 vials; Lot: Lot #: A240421, Exp 07/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

What to do

Voluntary: Firm initiated · Letter

Get an email if DEXAMETHASONE SODIUM PHOSPHATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXAMETHASONE SODIUM PHOSPHATE
Manufacturer
SOMERSET THERAPEUTICS LLC
Distributor
Nationwide in the USA
UPC
0370069025109
Lot
Lot #: A240421, Exp 07/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01 recalled?

Yes. FDA published recall D-0398-2026 on March 25, 2026. Reported hazard: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXAMETHASONE SODIUM PHOSPHATE. UPC: 0370069025109.